A Phase IV, Open-label 2 Arm Trial to Compare the Efficacy and Safety of a Pre-defined Dose of GONAL-f Based on Antral Follicle Count [Follicles ≥2mm - < 11mm]), or AMH for Ovarian Stimulation in Subjects Undergoing Assisted Reproductive Technology (ART) Treatment.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2013
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 12 Feb 2013 New trial record